Skip to main content

Table 6 Multivariate analysis of prognosis and related factors of epithelial ovarian cancer

From: Effect of bevacizumab combined with chemotherapy on SDF-1 and CXCR4 in epithelial ovarian cancer and its prognosis

Factor

β

SE

Wald

P

OR

95% CI

Chemotherapy regimen

1.158

2.369

0.000

0.001

1.253

0.430~13.268

Clinical staging

1.103

1.780

0.832

0.024

1.000

0.231~4.251

SDF-1

1.083

1.294

0.759

0.012

1.643

0.172~20.000

CXCR4

2.307

3.852

0.174

0.046

1.736

0.024~2.452